top of page
tokers-guide-find-the-best-weed-in-dc-lo
NEW 1 to 1 photo editing 122024 (17).png
MediPharm Labs Corp. announced that board member Shelley Potts will step down on December 31, 2025, and Michael Bumby will assume the role effective January 1, 2026. Bumby previously served as a board member and CFO of VIVO Cannabis Inc., which MediPharm acquired in 2023, and has senior experience in global pharmaceutical companies.

Potts Out, Bumby in on MediPharm Labs Board

Dec 11, 2025

Mg Magazine Newswire

MG Magazine



*TORONTO* — MediPharm Labs Corp. board of directors member Shelley Potts
will be stepping down effective December 31, 2025. Michael Bumby will
replace her effective January 1, 2026.

Bumby previously served on the Board and was Chief Financial Officer at
VIVO Cannabis Inc., which MediPharm acquired in 2023. In addition to his
experience in the cannabis sector, he has held senior leadership roles in
global pharmaceutical companies, providing strategic and financial
oversight across highly regulated markets.

Recent Reviews

bottom of page